WHO ICTRP trial

A Phase III Multicenter, Randomized, Double-Blind Trial to Assess the Safety and…

EUCTR2007-000498-42-GB · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2007-000498-42-GB
Public title A Phase III Multicenter, Randomized, Double-Blind Trial to Assess the Safety and Efficacy of Two Parallel Dose Groups of Plant Cell Expressed Recombinant Human Glucocerebrosidase (prGCD) in Patients with Gaucher Disease - NA
Scientific title A Phase III Multicenter, Randomized, Double-Blind Trial to Assess the Safety and Efficacy of Two Parallel Dose Groups of Plant Cell Expressed Recombinant Human Glucocerebrosidase (prGCD) in Patients with Gaucher Disease - NA
Primary sponsor Protalix Biotherapeutics
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no
Countries Spain;Italy;United Kingdom
Conditions Gaucher disease MedDRA version: 9.1 Level: PT Classification code 10018048 Term: Gaucher's disease
Interventions Product Name: recombinant human glucocerebrosidase Product Code: prGCD Pharmaceutical Form: Powder for solution for infusion Current Sponsor code: prGCD Other descriptive name: recombinant human glucocerebrosidase Concentration unit: U…
Registration date Jul 1, 2008
Target size 30
Secondary IDs PB-06-001
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations